【24h】

Study on the compatibility of cefotaxime with tinidazole in glucose injection.

机译:头孢噻肟与替硝唑在葡萄糖注射液中的相容性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

An efficient HPLC method for the compatibility study of cefotaxime with tinidazole in glucose injection is described, which has been developed for the simultaneous determination of cefotaxime and tinidazole in glucose injection. The appearance and pH value of the mixed solution were investigated and the concentrations of cefotaxime and tinidazole were determined by RP-HPLC with an Agilent ZORBAX Eclipse XDB-C8 column, gradient elution and dual wavelength detection on diode-array-detector (DAD) at room temperature (20 degrees C) within 24 h. It was found that the resulting appearance and pH value of the mixed solution showed slight changes, on the other hand, the quantity of cefotaxime decreased significantly. The results show that the mixed solution of cefotaxime with tinidazole in glucose injection must be used within 8 h in clinical due to the possible degradation of cefotaxime in tinidazole glucose injection. This study provides a convenient method for rational use of compatible drugs in clinical practice.
机译:描述了一种高效液相色谱法,用于研究头孢噻肟与替硝唑在葡萄糖注射液中的相容性,该方法已开发用于同时测定头孢噻肟和替硝唑在葡萄糖注射液中的含量。研究了混合溶液的外观和pH值,并通过使用安捷伦ZORBAX Eclipse XDB-C8柱的RP-HPLC,梯度洗脱和二极管阵列检测器(DAD)上的双波长检测,测定了头孢噻肟和替硝唑的浓度。在24小时内达到室温(20摄氏度)。发现混合溶液的所得外观和pH值显示出微小变化,另一方面,头孢噻肟的量显着降低。结果表明,由于头孢噻肟在替硝唑葡萄糖注射液中可能降解,因此临床上必须在8小时内使用头孢噻肟与替硝唑的混合溶液。这项研究为在临床实践中合理使用兼容药物提供了便利的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号